Can low doses of simvastatin enhance fracture healing? An experimental study in rabbits

Injury

Volumn 41, Issue 7, 2010, Pages 687-692

  Chissas, Dionysios ^a   Stamatopoulos, George ^a   Verettas, Dionysios ^d   Kazakos, Konstantinos ^d   Papalois, Apostolos ^b   Agrogiannis, George ^c   Papaeliou, Athanasios ^a   Agapitos, Emmanouel ^c   Balanika, Alexia ^c   Papadopoulou, Eleftheria ^e   Anastopoulos, George ^a   Ntagiopoulos, Panagiotis G ^a   Asimakopoulos, Antonios ^a  

^a KAT HOSPITAL   (Greece)

^b ELPEN Pharmaceuticals   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^e UNIVERSITY OF PATRAS   (Greece)

Author keywords

Biomechanics; Fracture healing; Histomorphometry; PQCT; Simvastatin

Indexed keywords

SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BLOOD CELL COUNT; BONE DENSITOMETRY; BONE DENSITY; BONE REMODELING; CALLUS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; ENERGY; EXPERIMENTAL STUDY; FRACTURE HEALING; LOW DRUG DOSE; MALE; MORPHOMETRICS; NONHUMAN; OSTEOTOMY; PRIORITY JOURNAL; QUANTITATIVE STUDY; RABBIT; RIGIDITY; THERAPY EFFECT;

EID: 77957127493     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2009.10.011     Document Type: Article

References (25)

1. Blum CB. Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. AmJ Cardiol 1994; 73 (14): 3D-11D.
2. Bolego C, Baetta R, Bellosta S, et al. Safety considerations for statins. Curr Opin Lipidol 2002; 13 (6): 637-44.
3. Bouxsein ML, Turek TJ, Blake CA. et al. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am 2001; 83-A(8): 1219-30.
4. Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethylglutarylcoenzyme A reductase and risk of fracture among older women. Lancet 2000; 355 (9222): 2185-8.
5. Gerson RJ, MacDonald JS. Alberts AW. et al. Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors. Am J Med 1989; 87 (4A): 28S-38S.
6. Gerstenfeld LC. Wronski TJ, Hollinger JO, Einhorn TA. Application of histomorphometric methods to the study of bone repair. J Bone Miner Res 2005; 20 (10): 1715-22.
7. Hacker SA, Healey RM, Yoshioka M, Coutts RD. A methodology for the quantitative assessment of articular cartilage histomorphometry. Osteoarthritis Cartilage 1997; 5 (5): 343-55.
8. Hatano H, Maruo A, Bolander ME, Sarkar G. Statin stimulates bone morphogenetic protein-2. aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytes. J Orthop Sci 2003; 8 (6): 842-8.
9. Lupattelli G, Scarponi AM, Vaudo G, et al. Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women. Metabolism 2004; 53 (6): 744-8.
10. Maeda T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 2001; 280 (3): 874-7.
11. Maritz FJ, Conradie MM, Hulley PA, et al. Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler Thromb Vasc Biol 2001; 21 (10): 1636-41.
12. Melton LJ. 3rd: how many women have osteoporosis now? J Bone Miner Res 1995; 10 (2): 175-7.
13. Montagnani A. Gonnelli S. Cepollaro C. et al. Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study. Bone 2003; 32 (4): 427-33.
14. Mundy G, Garrett R. Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999; 286 (5446): 1946-9.
15. O'Driscoll SW, Marx RG, Fitzsimmons JS, Beaton DE. Method for automated cartilage histomorphometry. Tissue Eng 1999; 5 (1): 13-23.
16. Ohno T. Shigetomi M. Ihara K, et al. Skeletal reconstruction by vascularized allogenic bone transplantation: effects of statin in rats. Transplantation 2003; 76 (5): 869-71.
17. Oxlund H, Andreassen TT. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation. Bone 2004; 34 (4): 609-18.
18. Reid IR, Hague W. Emberson J. et al. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease. Lancet 2001; 357 (9255): 509-12.
19. Reid IR, Tonkin A, Cannon CP. Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial-secondary analysis of a randomized controlled trial. Bone 2005; 37 (2): 190-1.
20. Rejnmark L, Buus NH, Vestergaard P, et al. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res 2004; 19 (5): 737-44.
21. Rejnmark L, Olsen ML, Johnsen SP, et al. Hip fracture risk in statin users - a population-based Danish case-control study. Osteoporos Int 2004; 15 (6): 452-8.
22. Schoofs MW, Sturkenboom MC, van der Klift M, et al. HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res 2004; 19 (9): 1525-30.
23. Skoglund B, Forslund C, Aspenberg P. Simvastatin improves fracture healing in mice. J Bone Miner Res 2002; 17 (11): 2004-8.
24. Tikiz C, Tikiz H, Taneli F, et al. Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year followup study. Clin Rheumatol 2005; 24 (5): 447-52.
25. Wang JW, Xu SW, Yang DS, Lv RK. Locally applied simvastatin promotes fracture healing in ovariectomized rat. Osteoporos Int 2007; 18 (12): 1641-50.